The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells

Mucosal Immunology

Volumn 7, Issue 4, 2014, Pages 958-968

  Meylan, F ^a   Hawley, E T ^a   Barron, L ^b   Barlow, J L ^c   Penumetcha, P ^a   Pelletier, M ^a   Sciume G ^a   Richard, A C ^a   Hayes, E T ^a   Gomez Rodriguez, J ^d   Chen, X ^b   Paul, W E ^b   Wynn, T A ^b   McKenzie, A N J ^c   Siegel, R M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DEATH RECEPTOR 3; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; METRONIDAZOLE; NEOMYCIN; NEOMYCIN TRISULFATE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VANCOMYCIN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; CYTOKINE; PROTEIN BINDING;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTEROPATHY; GROUP 2 INNATE LYMPHOID CELL; HELMINTH; IMMUNOPATHOLOGY; INTESTINE; LUNG DISEASE; LYMPHOID CELL; MOUSE; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; KNOCKOUT MOUSE; LUNG; MAST CELL; METABOLISM; MICROBIOLOGY; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY; IMMUNITY, INNATE; INTERLEUKIN-13; INTESTINAL MUCOSA; LUNG; MAST CELLS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84902210026     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.114     Document Type: Article

References (49)

1. Croft, M. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9, 271-285 (2009
2. Migone, T.S. et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492 (2002
3. Prehn, J.L., Thomas, L.S., Landers, C.J., Yu, Q.T., Michelsen, K.S. & Targan, S.R. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J. Immunol. 178, 4033-4038 (2007
4. Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89 (2008
5. Meylan, F, Richard, A.C. & Siegel, R.M. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol. Rev. 244, 188-196 (2011
6. Pappu, B.P. et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp.Med. 205, 1049-1062 (2008
7. Bull, M.J. et al. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 205, 2457-2464 (2008
8. Takedatsu, H. et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135, 552-567 (2008
9. Buchan, S.L., Taraban, V.Y., Slebioda, T.J., James, S, Cunningham, A.F. & Al-Shamkhani, A. Death receptor 3 is essential for generating optimal protective CD4(+) T-cell immunity against Salmonella. Eur. J. Immunol. 42, 580-588 (2012
10. Twohig, J.P. et al. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4(+) and CD8(+) T-cell immunity. FASEB J. 26, 3575-3586 (2012
11. Bamias, G. et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171, 4868-4874 (2003
12. Zhang, J. et al. Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 183, 5350-5357 (2009
13. Bamias, G, Siakavellas, S.I., Stamatelopoulos, K.S., Chryssochoou, E, Papamichael, C & Sfikakis, P.P. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 129, 249-255 (2008
14. Barrett, J.C. et al. Genome-wide association Defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008
15. Taraban, V.Y. et al. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4, 186-196 (2011
16. Meylan, F. et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 4, 172-185 (2011
17. Shih, D.Q. et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS ONE 6, e16090 (2011
18. Twohig, J.P. et al. Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3. J. Neurosci. 30, 3782-3792 (2010
19. McLaren, J.E. et al. The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J. Immunol. 184, 5827-5834 (2010
20. Walker, J.A., Barlow, J.L. &McKenzie, A.N. Innate lymphoid cells-how did we miss them?. Nat. Rev. Immunol. 13, 75-87 (2013
21. Spits, H. et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013
22. Sawa, S. et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330, 665-669 (2010
23. Wong, S.H. et al. Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 13, 229-236 (2012
24. Yang, Q. et al. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38, 694-704 (2013
25. Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissueassociated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540-544 (2010
26. Neill, D.R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-U9 (2010
27. Yang, Q, Saenz, S.A., Zlotoff, D.A., Artis, D & Bhandoola, A. Cutting edge: Natural helper cells derive from lymphoid progenitors. J. Immunol. 187, 5505-5509 (2011
28. Maynard, C.L., Elson, C.O., Hatton, R.D. & Weaver, C.T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241 (2012
29. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012
30. Price, A.E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494 (2010
31. Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12, 1071-1077 (2011
32. Barlow, J.L. et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129, 191-198. e1-4 (2012
33. Roediger, B. et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14, 564-573 (2013
34. Hung, L.Y. et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc. Natl. Acad. Sci. USA 110, 282-287 (2013
35. Fallon, P.G. et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105-1116 (2006
36. Chiaramonte,M.G., Donaldson, D.D.,Cheever,A.W.& Wynn, T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104, 777-785 (1999
37. Chiaramonte,M.G., Schopf, L.R., Neben, T.Y., Cheever, A.W., Donaldson, D.D. & Wynn, T.A. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162, 920-930 (1999
38. Sokol, C.L., Chu, N-Q., Yu, S, Nish, S.A., Laufer, T.M. & Medzhitov, R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 10, 713-720 (2009
39. Tang, H. et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat. Immunol. 11, 608-617 (2010
40. Kamijo, S. et al. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J. Immunol. 190, 4489-4499 (2013
41. Pichery,M. et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: In situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188, 3488-3495 (2012
42. Halim, T.Y., Krauss, R.H., Sun, A.C. & Takei, F. Lung natural helper cells are a critical source of Th2 cell-Type cytokines in protease allergen-induced airway inflammation. Immunity 36, 451-463 (2012
43. Paul, W.E. & Zhu, J. How are TH2-Type immune responses initiated and amplified? Nat. Rev. Immunol. 10, 225-235 (2010
44. Monticelli, L.A. et al. Innate lymphoid cells promote lung-Tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054 (2011
45. Mjosberg, J.M. et al. Human IL-25- And IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055-1062 (2011
46. Wang, E.C.Y., Thern, A, Denzel, A, Kitson, J, Farrow, S.N. & Owen, M.J. DR3 regulates negative selection During thymocyte development. Mol. Cell. Biol. 21, 3451 (2001
47. Camberis, M, Le Gros, G & Urban, J Jr Animal model of Nippostrongylus brasiliensis and Heligmosomoides polygyrus. Curr. Protoc. Immunol., Chapter 19:Unit 19 2 (2003
48. Lewis, F. Schistosomiasis. Curr. Protoc. Immunol., Chapter 19:Unit 19 1 (2001
49. Khodoun, M. et al. Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses. J. Immunol. 179, 6429-6438 (2007.